KBR (KBR)
(Delayed Data from NYSE)
$66.79 USD
+0.28 (0.42%)
Updated May 3, 2024 04:00 PM ET
After-Market: $66.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
KBR, Inc. [KBR]
Reports for Purchase
Showing records 1 - 20 ( 624 total )
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Optimized Entry and Exit Levels for KBR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
Company: KBR, Inc.
Industry: Engineering - R and D Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: KBR, Inc.
Industry: Engineering - R and D Services
EC: Terminating Coverage of 7 Companies,Suspending Coverage of 11
Provider: KeyBanc Capital Markets
Analyst: Research Department